Effect of rMnSOD on sodium reabsorption in renal proximal tubule in

Ochratoxin A - treated rats by Damiano, Sara et al.
Effect of rMnSOD on Sodium Reabsorption in Renal
Proximal Tubule in Ochratoxin A—Treated Rats
Sara Damiano,1 Maria V. Puzio,1 Caterina Squillacioti,1 Nicola Mirabella,1 Enrica Zona,2
Aldo Mancini,3 Antonella Borrelli,4 Carlo Astarita,5,6 Silvia Boffo,6 Antonio Giordano,6
Luigi Avallone,1 Salvatore Florio,1 and Roberto Ciarcia 1*
1Department of Veterinary Medicine, Animal Productions, University of Naples “Federico II,” 80137, Naples, Italy
2Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy
3Laedhexa Biotechnologies Inc., Laedhexa Biotechnologies Inc., San Francisco, California
4Department of Molecular Biology and Biotherapy, National Cancer Institute “G. Pascale” Naples, Naples, Italy
5Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy
6Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, College of Science and
Technology, Temple University, Philadelphia, Pennsylvania
ABSTRACT
OchratoxinA (OTA) is amycotoxin produced byAspergillus andPenicillium that represent toxic real threat for human beings and animal health.
In this study we evaluated the effect of a new recombinant mitochondrial manganese containing superoxide dismutase (rMnSOD) on oxidative
stress and on the alterations of ﬂuid reabsorption in renal proximal tubule (PT) as possible causes of OTA nephrotoxicity. Finally, we have
measured the concentration of O2
 in the kidney through dihydroethidium assay (DHE) and nitric oxide (NO) concentration through nitrites and
nitrates assay. Male Sprague Dawley rats weighing 120–150g were treated for 14 days by gavage, as follows: Control group, 12 rats received a
corresponding amount of saline solution (including 10%DMSO); rMnSODgroup, 12 rats treatedwith rMnSOD (10mg/kg bw); OTA group, 12 rats
treated with OTA (0.5mg/kgbw) dissolved in 10% DMSO and then scaled to required volume with corn oil; rMnSODþOTA, 12 rats treated with
rMnSOD (10mg/kg bw) plus OTA (0.5mg/kg bw). Our results have shown that rMnSOD restores the alteration of reabsorption in PT in rats treated
with OTA plus rMnSOD, probably through the response to pressure natriuresis, where nitric oxide plays a key role. Moreover, rMnSOD prevents
the nephrotoxicity induced by OTA probably restoring the balance between superoxide and NO that is most probably the cause of hypertension
and renal functional alterations through the inhibitionofNO synthase. In conclusion these data provide important information for understanding
of mechanism of toxic action of OTA. J. Cell. Biochem. 119: 424–430, 2018. © 2017 Wiley Periodicals, Inc.
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Ochratoxin A (OTA) is a natural mycotoxin produced byﬁlamentous mold species belonging to the generaAspergillus
and Penicillium. It is distributed in food and feedstuffs due to fungi
contamination in susceptible agricultural commodities [Wu et al.,
2011]. Several studies have shown that OTA is nephrotoxic,
hepatotoxic, teratogenic, neurotoxic, immunotoxic, genotoxic,
and carcinogenic in several animal species, with the longest half-
life in human blood [Ringot et al., 2006; El Khoury and Atoui, 2010;
Malir et al., 2013]. In addition, chronic exposure to low doses could
be more dangerous that acute exposure to high doses [Pfohl-
Leszkowicz and Manderville, 2007]. OTA is absorbed in small
intestinal absorption, enters in the bloodstreamwhere it binds serum
proteins and it is subsequently distributed to different tissues and
organs [Hagelberg et al., 1989]. Humans are exposed to OTA through
various routes, especially through dietary intake, as well as through
skin contact or inhalation exposure, although they are less important
than the food [Iavicoli et al., 2002; Degen et al., 2007].
The kidney is the primary target of OTA. It has been shown to
induce Balkan Endemic Nephropathy, kidney tumors and chronic
interstitial nephropathy [Maarouﬁ et al., 1995; Fuchs and Peraica,
2005]. Kidney lesions have been observed in the proximal tubule
(PT), regarded the main intrarenal target of the OTA, such as damage
of epithelial cells, reduction of the size and the density of brush
border. Moreover, the hystological data shows an enlargement of
tubular membrane [Schaaf et al., 2002].
The mechanism of OTA toxicity has not yet been clearly
elucidated. Several studies have demonstrated that OTA induced
nephrotoxicity and hepatotoxicity through oxidative DNA damage
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in vitro [Kamp et al., 2005] and in vivo [Meki and Hussein, 2001;
Di Giacomo et al., 2007]. Physical, chemical, and biological
methods have been developed to reduce the toxic action of OTA
[Zinedine et al., 2007; Battacone et al., 2010]. In several studies,
the attention has been focused on natural antioxidant constitu-
ents, as such as polyphenols, vitamin C, vitamin E, and retinol
(vitamin A) [Bose and Sinha, 1994; Kumari and Sinha, 1994;
Hoehler and Marquardt, 1996; Grosse et al., 1997]. Polyphenols are
secondary metabolism products of plants, and constitute one of the
most numerous and widely distributed group of natural anti-
oxidants that actually appear reduce the toxic effects caused by
OTA. In contrast, vitamin E seems to not counteract the toxicity of
OTA in HepG2 cells [Gayathri et al., 2015].
In an our previously paper we have evaluated the mechanism of
chronic nephrotoxic diseases induced by OTA. In particular, we
have demonstrated, in a rat animal model treated for 2 weeks
with OTA that the increase in Reactive Oxigen Species (ROS)
productions was linked to a strong reduction of glomerular ﬁltration
rate (GFR) and with a signiﬁcant increase in blood pressure (BP).
Moreover, in rat treated with OTA plus the new recombinant
mitochondrial manganese superoxide dismutases (rMnSOD), the
kidney functions and the lipidic peroxidation levels were preserved
[Ciarcia et al., 2016].
rMnSOD ia a new isoform of humanMnSOD that was isolated and
obtained in a synthetic recombinant form. It is able to enter into cells
and it appears to have antioxidant and antitumor activities [Mancini
et al., 1999, 2006]. Moreover, rMnSOD is radioprotective for healthy
cells and radiosensitive for cancer cells [Borrelli et al., 2009], it
displays a speciﬁc and selective cytotoxic activity against tumor
cells expressing the oestrogen receptor [Mancini et al., 2008]. We
have also demonstrated, that rMnSOD provides protection to rat
kidneys treated with cyclosporine A, allowing for the recovery of
80% of their GFR [Damiano et al., 2013].
In the present paper, the effects of rMnSOD on renal kidney injury
induced by OTA were evaluated. In particular, we have studied the
involvement of PT through in vivo micropuncture studies. In
addition, we have analyzed the alteration of the most important
sodium transport in the proximal tubule, the sodium-hydrogen
exchangers (NHE3) to determinewhether the change in absorption of
liquids in PT was linked to sodium reabsorption change. Finally, we
have measured the concentration of O2
 in the kidney through
dihydroethidium assay (DHE) and nitric oxide (NO) concentration
through nitrites and nitrates assay.
MATERIALS AND METHODS
CHEMICALS AND REAGENTS
The rats were obtained from Harlan Laboratories Srl (San Pietro al
Natisone, Udine, Italy); Ochratoxin A (OTA), FITC-inulin and all the
reagents were provided by Sigma–Aldrich (Milan, Italy), rMnSOD
was obtained by Laedhexa Biotechnologies Inc., San Francisco, CA
and the, Department of Experimental Oncology, Istituto Nazionale
Tumori “Fondazione G. Pascale,” IRCCS (Naples, Italy) [Mancini
et al., 2006]. Anti-NHE3 antibody were purchased by Tema Ricerca
srl (Bologna, Italy).
ETHICS STATEMENT
This study was carried out in accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by Italian
Ministry of Health (Permit Number: 2015-261-PR).
EXPERIMENTAL PROTOCOL
Experiments were performed on a total of 48 adult male Sprague
Dawley rats weighing 120–150 g. They were housed under constant
environmental conditions (temperature 22°C and a 12 h light–dark
cycle). Animals were fed a standard diet; food and water were given
ad libitum. The rats, randomly divided into four groups, were treated
for 14 days by gavage, as follows: Group 1 (Control group), 12 rats
received a corresponding amount of saline solution (including 10%
DMSO); Group 2 (rMnSOD group), 12 rats treated with rMnSOD
(10mg/kg bw); Group 3 (OTA group): 12 rats treated with OTA
(0.5mg/kg bw) dissolved in 10% DMSO and then scaled to required
volume with corn oil; Group 4 (rMnSODþOTA), 12 rats treated with
rMnSOD (10mg/kg bw) plus OTA (0.5mg/Kg bw). The dose and
length of rMnSOD and OTA administration was chosen according to
previous experiments [Hoehler and Marquardt, 1996]. Blood
Pressure (BP) was recorded in anaesthetized rats, during the in
vivo micropuncture experiments, through the femoral artery using a
blood pressure recorder (Pressure Monitor BP-1, Word Precision
Instruments).
PREPARATION OF ANIMALS FOR IN VIVO MICROPUNCTURE
EXPERIMENT
The rats were anaesthetized with 2% isoﬂurane (Isotec 4, Ohmeda),
placed on a thermo-regulated table (37°C) and prepared for renal
micropuncture evaluation. The right femoral artery was then
cannulated with polyethylene tubing (PE 50) connected to a blood
pressure transducer (Statham) for continuous monitoring. A second
polyethylene tube was placed in the left jugular vein and connected
to an infusion pump (Braun, Germany) that delivered a modiﬁed
Ringer’s solution (NaCl 125mmol/L1; NaHCO3 25mmol . L
1) at a
rate of 1.8ml . h1. The left kidney was then exposed through a ﬂank
incision, cleared of perirenal fat and immobilized in a plastic kidney
cup with agar (3% in saline), and then bathed with warmed mineral
oil. Thirty to sixty minutes was allowed after surgery before
beginning tubule micropuncture.
IN VIVO MICROPUNCTURE STUDY
The proximal tubule (PT) site was identiﬁed by injections from a
“ﬁnding” pipette containing dye-stained artiﬁcial tubular ﬂuid.
The ﬂow was blocked by injection of T grease (T grade, Apiezon
Products, Manchester, UK) via a micropipette (10–12mm OD)
proximal to the perfusion site. The tubule was perfused with a
micropipette (tip diameter 8–10mm OD) connected to a micro-
perfusion pump (model A1400, World Precision Instruments
Inc, Sarasota, FL) at 20 3 nl/min. The perfusion solution
contained FITC-inulin (Sigma) as volume marker and 0.1%
FD&C green dye for identiﬁcation of the perfused loops. Tubules
were perfused for 2 to 8 min before ﬂuid collections, which were
made at a downstream site with a micropipette (7–10mm OD)
after placement of a column of oil to block downstream ﬂow.
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Samples were collected for 3–5 min and transferred into a
constant-bore capillary tube for which the length was measured
with a micrometer to calculate the tubular ﬂuid volume.
Thereafter, FITC-inulin ﬂuorescence was determined in samples
and standards using a 96-well plate reader with excitation and
emission wavelengths of 490 and 520 nm, respectively.
Collected samples with 95% and 105% of microperfused inulin
were discarded. To determine the lengths of the perfused
segments, tubules were ﬁlled with high-viscosity microﬁl (Flow
Tech, Inc. Carver, MA). At the end of the experiments, the
kidney was partially digested in 20% NaOH, and the casts were
measured under a dissecting microscope. The Absoluted ﬂuid
reabsorption (Jv) was calculated by the difference in the
perfusion rate and the collection rate factored by the length of
the nephron: Jv¼Vperf (nanoliters for minute)Vcoll (nanoliters
per minute)/PT length (millimeters) where Vperf indicates
perfusion rate and Vcoll indicates collection rate and expressed
as nanoliters per minute per millimeter. The composition of the
perfusion ﬂuid was as follows in mM: 125 NaCl, 20 NaHCO3, 5
KCl, 1 MgSO4, 2 CaCl, 1 NaHPO4, 5 glucose, and 4 urea. At the
end of each experiment, tubular ﬂuid samples were transferred
individually to 0.5 ml constant-bore Microcaps to determinate
the volume. Then FITC-labeled inulin ﬂuorescence was deter-
mined in samples and standards using a Spectra Max2 plate
reader with excitation and emission wavelengths of 490 and
520 nm, respectively, according to Lorenz and Gruenstein
(1999).
ANTI-NHE3 WESTERN BLOT EXPERIMENT
Western blot analysis was performed to determine the relative
amounts of the protein present in different samples. Samples,
prepared from cortical kidney tissues, were homogenized in a
lysis buffer (sucrose 0.3 M, imidazole 0.5 M, EDTA 0.5M,) with a
protease inhibitor Mix (cat. n. 39102.01, SERVA) which protects
proteins of interest from degradation. The samples were loaded
on NuPage Bis-Tris gel 4–12% (Novex by Lifetech) with sample
reducing buffer 10 (Invitrogen) and fourX LDS NuPAGE
Sample Buffer (Invitrogen) after boiling for 15 min at 70°C. The
20Mops SDS Buffer (Novex by Lifetechnologies) and NuPAGE
Antioxidant (Invitrogen) were used for proteins electrophoretic
separation for 60min at 200 volts in a Novex Mini-cell
electrophoresis chamber (Invitrogen). Later proteins were
transfered to Invitrolon PVDF ﬁlter paper sandwich (0.4mm
pore size, Invitrogen), activated with methanol for 5 min, using
20 Transfer Buffer NuPAGE (Novex by Lifetech) for 70 min at
30 volts. The PVDF membrane was incubated with casein I-
block (Tropix) for 1 h; then it was incubated with the primary
rabbit polyclonal antibody anti NHE-3 (cat. n.TA 309445,
OriGene), diluited 1:1000 in I-block over night at 4°C and with
the primary rabbit polyclonal antibody anti actin (cat. n. TA
349206, OriGene), diluited 1:1000 in I-block over night at 4°C.
The following day the blot, after washing with I-block three
times for 5 min per time, was exposed to secondary antibody-
enzyme conjugate to alkaline phosphatase (Applied Biosystems)
for 1 h. The membrane was washed again as above and
incubated with Western Light Plus Kit, CSPD, and Nitroblock
(Tropix), for 5 min to develop the chemiluminescent signal.
Proteins were visualized in the darkroom using photographic
plate (X-RAY FILM, FUJIFILM) for some minutes. The molecular
weight standards, SeeBlue Plus1 Prestained Standard 11
(Invitrogen), was used to identify proteins of interest on PVDF
ﬁlter paper. Densitometric analysis of the bands, normalized to
B-actin, was performed with ImageJ.
SUPEROXIDE ASSAY IN THE DISSECTED AORTA
Superoxide concentrations within the cells of the abdominal
aorta were evaluated by the oxidation of dihydroethidium
(DHE; Molecular Probes). DHE can enter the cell and be oxidized
by superoxide to yield ethidium (Eth), which binds DNA
producing bright red ﬂuorescence. The increase in Eth-DNA
ﬂuorescence indicates peroxide production within cells (30). The
Aorta was dissected and frozen at 80°C. Sections (10mm thick)
were cut at the cryostat (Leica CM 1850) and then incubated with
a 20mM DHE solution for 30min at room temperature. Cover
slips were mounted with Dako Fluorescence Mounting Medium.
Pictures were acquired at the Leica DMI6000 B inverted
microscope. Fluorescence intensity (IF) was quantiﬁed by Imagej
software. Brieﬂy, average pixel intensity was quantiﬁed from
three equal random areas from each sample. The average pixel
intensity was compared among groups. The data were expressed
as IF/g of tissue x micrograms of proteins.
NITRITE AND NITRATE ASSAY
The production of nitrite (NO2) and nitrate (NO3), stable
metabolites of NO production, was determined in the supernatant
of kidney cytosols by Griess reagent. Nitrate was reduced to nitrite
by addition of nitrate reductase (0.4 U/ml) in the presence of
10mM NADPH and 2.5mM ﬂavin adenin dinucleotide and then
assayed as nitrite. The plates were incubated with the Griess
reagent at 25°C under reduced light for 20min. Absorbance was
read at 550 nm using a Perkin Elmer UV Spectrophotometer. The
concentration of NO2 was calculated on a calibration curve (range:
0.125–16mg/ml), prepared using dilutions of sodium nitrate in the
plating medium. The data were expressed as picomoles of nitrite
for milligrams of proteins.
STATISTICAL ANALYSIS
All data are mean SD. Statistical analysis was performed by
one-way ANOVA followed by the unpaired t-test. A value of
P< 0.05 was considered statistically signiﬁcant.
RESULTS
EFFECT OF OTA ON BLOOD PRESSURE
As shown in the Figure 1, OTA signiﬁcantly increased blood pressure
(BP), expressed as mmHg, at 14 days of the treatment compared to
control. In fact BP values shifted by 98 4 control to 130 2 OTA
(P< 0.05 respect to control). However, the administration of
rMnSOD plus OTA restored this function from 130 2 OTA to 96 2
rMnSODþOTA (#P< 0.05). rMnSOD, utilized alone, had no effect on
BP (104 4).
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IN VIVO MICROPUNCTURE STUDY EVALUATION
As shown in Figure 2, the absoluted ﬂuid reabsorption (Jv) measured
in the PT averaged 2.5 0.3 nl/min/mm in control rats. However, Jv
was lower in PT of rat treated with OTA (1.6 0.2 nl/min/mm,
(P< 0.05 respect to control). Treatment with rMnSOD plus OTA
restored the Jv to normal levels (2.3 0.3 nl/min/mm respect to
2.5 0.3 nl/min/mm) (#P< 0.05 respect OTA alone). RMnSOD alone
had no effect on Jv (2.4 0.4 nl/min/mm).
WESTERN BLOT ANALYSIS OF NHE3
NHE3 protein abundance was determined by western blot
analysis, as shown in Figure 3. The antibody recognized a
protein with a molecular mass between 66 and 116 kDa.
Densitometric analysis have demonstrated that NHE3 abundance,
normalized for b-actin, is decreased in OTA group (control
17589 818 respect to OTA 6607 1961, P< 0.05). Moreover,
animals treated with OTA plus rMnSOD were similar to the
control group (17516 1391). rMnSOD alone had no effect on
NHE3 protein abundance respect to the control (22907 1403).
EFFECTS OF rMnSOD ON OTA-INDUCED OXIDATIVE STRESS
The red ﬂuorescence generated by the binding of the Eth–DNA
complex was showed that the abdominal aorta of OTA treated
animals presented a red ﬂuorescent signal signiﬁcantly brighter
than control (52532 4614 vs. 22522 5715, P< 0.05) (Fig. 4A,
C). When the rats were treated with OTA plus rMnSOD, the
ﬂuorescence intensity was signiﬁcantly lower than the OTA-
treated group (33101 3251) (Fig. 4D), indicating that rMnSOD
was able to completely prevent the production of superoxide
induced by OTA. rMnSOD treatment had no effect on the
ﬂuorescence intensity (31251 4210) (Fig. 4B).
NITRITE AND NITRATE ASSAY
As shown in the Figure 5, OTA decreased the NO production
(express as pmoles/mg of proteins) in rat kidney cytosol respect
to control (12.51 0.8 OTA respect to 25.08 1.0 control,
P< 0.05). Treatment with rMnSOD plus OTA restored the levels
of NO concentrations respect to OTA from 12.51 0.8 OTA to
23.02 2 rMnSODþOTA group. rMnSOD used alone, did not
show any signiﬁcant difference respect to control (25.08 1.0
and 24.09 1.1, respectively).
Fig. 1. Effects of OTA and rMnSOD used alone or in association on blood
pressure (BP) in rats treated for 2 weeks. OTA treatment signiﬁcantly increased
BP, while co-administration with rMnSOD restored this effect (values
mean SD; P< 0.05 vs. control group; #P< 0.05 vs. OTA group).
Fig. 2. Effects of OTA and rMnSOD used alone or in association on absoluted
ﬂuid reabsorption (Jv) in proximal tubule after 2 weeks of treatment. OTA
treatment signiﬁcantly decreased Jv in PT, while co-administration with
rMnSOD partially restored this effect (values mean SD; P< 0.05 vs. control
group; #P< 0.05 respect OTA group).
Fig. 3. Effects of OTA and rMnSOD used alone or in association on sodium-
hydrogen exchanger isoform 3 (NHE3) expression in the cortical rat kidney
after 2 weeks of treatment. OTA treatment signiﬁcantly decreased the NHE3
expression, while co-administration with rMnSOD partially prevent this effect,
on the contrary rMnSOD used alone signiﬁcantly increased the NHE3
expression (values mean SD; P< 0.05 vs. control group; #P< 0.05
respect OTA group). (A) shows the band intensity NHE3/beta-actin.Western
blot analysis of sodium transporter (NHE3) in the cortical kidney tissue. (B)
Summary graphs represent the average relative density of the bands
(normalized to b-actin) in the groups. P< 0.05 versus control rats.
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DISCUSSION
Although the correct mechanism of OTA nephrotoxicity is yet
unclear, several studies have proposed the involvement of
Reactive Oxigen Species (ROS) [Bhat et al., 2016; Ciarcia et al.,
2016]. It has been shown a signiﬁcant increase of ROS levels
and a severe reduction of antioxidant enzymes in OTA treated
cells showing lesions in the cell membrane, proteins, and DNA
[Baudrimont et al., 1997; Liu et al., 2012]. In accordance with
these authors, we have shown, in an our previous paper, that
three important parameters of oxidative stress, such as
malondialdehyde, SOD and catalase were altered in the kidney
of OTA treated rats [Ciarcia et al., 2016]. In the present study we
have measured the O2
 and NO production. DHE can enter the
cell and could be oxidized by superoxide to yield ethidium
which binds DNA producing red ﬂuorescence that indicates
peroxide production within the cell [Carter et al., 1994]. Our
results have shown that rMnSOD reduces the O2
 production
induced by OTA, conﬁrming the ability of rMnSOD to scavenge
many species of free radicals, probably through the presence of
the leader peptide that allows the rMnSOD to enter the cell
preventing its degradation by circulating proteases. We have
also investigated the link between the O2
 and NO production,
ﬁnding that the increase of O2
 was linked to the reduction of
the NO concentration. The link O2
 /NO is most probably the
cause of hypertension and renal functional alterations through
the inhibition of NO synthase (NOS). In our animal model of rat
treated with OTA for 14 days, we have found a signiﬁcant
increase in blood pressure, such ﬁnding agree with the result of
Wang et al. (2016) who observed a decrease of the vasodilator
NO during some pathophysiological processes, such as hyper-
tension.The most important ﬁnding of this work is that the ﬂuid
reabsorption in the PT of OTA treated group was impaired
compared to control group. Treatment with rMnSOD restored
the lower value of Jv in PT, suggesting that the hypertensive
effect of OTA could be related to O2
. Moreover, our data have
shown a decrease of NHE3 expression in hypertensive rats
treated with OTA. NHE3 is the major transporter of sodium in
the PT and it is involved in the pathogenesis of hypertension
[Dagher and Sauterey, 1992]. Thus, our data demostrated that
the decrease in PT by NHE3 plays a crucial role in the
hypertension induced by OTA. In fact, it has been demostrated
that sodium transport is inibited in the PT when the blood
pressure increases and NO has been identiﬁed as pivotal
candidate to mediate this process, though the pressure–
natriuresis response [Salom et al., 1992]. Some experiments
have demonstrated that the block of the basal synthesis of NOS
by Ng-monomethyl-L-arginine induced a signiﬁcant decrease
of Jv and HCO3 in the PT in the rat kidney [Wang, 1997; Wang
et al., 2000] and a similar result has been observed by Wang
[2002] in NOS knockout mice. The physiological importance of
the regulation in PT by NOS is unclear. A previous study has
demonstrated a stimulatory pathway at the low NO concentra-
tion and an inhibitory pathway at high NO concentrations
[Dagher and Sauterey, 1992], indicating that NO regulates the
transport of Naþ and HCO3
 in the PT.
Fig. 4. Effects of OTA and rMnSOD used alone or in association on O2
production in rat kidney after 2 weeks of treatment by dihydroethidium (DHE)
assay. (A) Representative pictures of DHE staining on the rat aorta. OTA
treatment induces an increase of DHE ﬂuorescence signal as the expression of
superoxide-mediated intracellular injury. rMnSOD prevents OTA-induced
injury on the aorta. (B) Fluorescence intensity quantiﬁcation. Fluorescence
intensity was quantiﬁed by Imagej software. Brieﬂy, average pixel intensity was
quantiﬁed from three equal random areas from each sample (values
mean SD; P< 0.05 vs. control group; #P< 0.05 respect OTA alone).
Fig. 5. Effects of OTA and rMnSOD used alone or in association on nitric oxide
(NO) production in rat kidney after 2 weeks of treatment measured by Griess
reagent. NO production is reduced OTA treatment showed a signiﬁcant
reduction in NO respect to control. (values are mean SD, P< 0.05 vs. control
group; #P< 0.05 respect OTA alone).
JOURNAL OF CELLULAR BIOCHEMISTRY428 ROLE OF rMnSOD ON OTA-NEPHROTOXICITY
Our data, together, suggest that O2
 inhibits the activity of
NHE3 probably through the link O2
/NO. In fact, some authors
have demonstrated that the NHE3 activity is inactivated in
Spontaneously Hypertensive Rat, probably through the in-
volvement of the regulatory factor for NHE3. In accordance
with this hypertensive model, in this paper we have shown a
severe decrease of NHE3 activity in PT in OTA hypertensive rats.
Therefore, it is possible that high renal levels of O2
 lead to
translocation of NHE3, and that the antioxidant rMnSOD could
reactivate this pathway. In conclusion, in this paper have
demostrated that O2
 could reduces NHE3 activity and also
inhibits ﬂuid uptake. These data suggest that increased reactive
oxygen species alters proximal tubular reabsorption during
hypertension induced by OTA and impacts renal regulation of
ﬂuid and solute balance.
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